The metabolic question.
A clinical investigation guide for adults with insulin resistance, weight resistance, or metabolic dysfunction unresponsive to standard interventions. The evidence here is earlier-stage — flagged honestly.
A workup for the metabolism that won't move.
This guide is written for the patient whose lab pattern says 'metabolic syndrome' but whose intervention plan keeps stalling — diet, training, and sleep all in order, scale and HOMA-IR refusing to move. It maps four pathways under active investigation in the H. pylori metabolic literature.
The evidence here is earlier-stage than the rest of the series — flagged honestly. It is not a treatment protocol. It is a structured exploration of a hypothesis worth ruling in or out.
-
i.
The clinical signature of resistant metabolic dysfunctionHow the picture differs from straightforward insulin resistance, NAFLD, and lipodystrophy patterns.
-
ii.
Four pathways under investigationInsulin signalling, microbiome ecology, ghrelin dysregulation, hepatic inflammation — with the evidence tier for each.
-
iii.
Why an 'OK' HbA1c doesn't always mean an OK metabolismFasting insulin, HOMA-IR, hs-CRP, GGT — what a single number obscures.
-
iv.
Labs to request beyond a basic metabolic panelFasting insulin, HOMA-IR, hs-CRP, GGT, fasting leptin — read together.
-
v.
Testing options for H. pyloriStool antigen, urea breath test, biopsy — trade-offs, costs, and what each rules in or out.
-
vi.
What positivity changesEradication, metabolic re-test at 6 months, longitudinal tracking — what to expect from an exploratory pathway.
-
vii.
A conversation script for the next appointmentThree questions, phrased clinically, that frame the gastric pathway as a hypothesis to test — not a diagnosis to chase.
How an unsuspected infection shifts the set-point.
Metabolic dysregulation in the presence of H. pylori sits at the exploratory edge of the literature. The guide treats each pathway as testable, with evidence tiers explicit and honest about uncertainty.
Insulin signalling interference
Sustained low-grade IL-6 / TNF-α elevations from gastric immune activity have been associated with insulin receptor dysregulation in adipose and hepatic tissue.
Microbiome ecology shift
Chronic H. pylori-associated gastric pH change cascades downstream, altering colonic short-chain fatty acid production. Investigated in pilot cohorts.
Ghrelin dysregulation
H. pylori-positive subjects show altered fasting ghrelin and post-prandial leptin response compared with H. pylori-negative controls in cross-sectional work.
Hepatic inflammation
Sustained systemic inflammation from chronic H. pylori has been associated with subclinical hepatic inflammation markers and NAFLD progression.
Sharper questions. Better appointments.
The guide doesn't replace a clinician. It gives you the language, the labs, and the literature — so the visit is a clinical exploration, not a search.
-
Recognise the clinical signature of resistant metabolic dysfunction and how it differs from straightforward insulin resistance, NAFLD, and lipodystrophy patterns.
-
Name the four pathways — insulin signalling, microbiome ecology, ghrelin dysregulation, hepatic inflammation — under active investigation in the literature.
-
Request the right secondary labs — fasting insulin, HOMA-IR, hs-CRP, GGT, fasting leptin — and read them in combination, not in isolation.
-
Decide between testing options — stool antigen, urea breath test, biopsy — based on cost, accuracy, and your specific clinical context.
-
Bring a structured exploration to your physician — three concrete questions that frame the gastric pathway as a hypothesis to test, not a diagnosis to chase.
Three tiers. One rubric. No exceptions.
Every claim in this guide is tagged with one of three evidence tiers. The summary below previews the four claims central to the case for investigating H. pylori in resistant metabolic dysfunction — with the exploratory tier well represented. The full reference list — nine citations — sits at the back of the PDF.
Metabolic · evidence summary
A few honest questions.
Is this medical advice?
No. It is an investigation guide — written to inform the conversation with a clinician. Diagnosis and treatment decisions belong to your physician.
Do I need to buy the testing kit?
No. The guide is content, sold separately from any Welyon product. It covers all three standard testing options — stool antigen, urea breath test, biopsy — and tells you what each costs and how to ask for it through your existing physician or insurer.
What if my labs are 'in range'?
The guide spends a section on this exact situation — what 'in range' obscures, what to look at in combination, and the secondary markers that frequently shift the picture without changing the headline numbers.
Refund policy?
14 days, no questions. If the guide isn't useful, the Lemon Squeezy receipt has a one-click refund link. We track this to keep the guides accountable.
Who wrote it?
The investigation series is authored by Welyon's editorial team and is being reviewed by the scientific advisory board currently in formation. Reviewer names will appear in the front matter of each guide upon confirmation.
Take metabolic resistance off the 'compliance' shelf. Investigate the variable.
30 pages, nine citations, four pathways under investigation, one structured exploration. PDF, instant download.
FDA disclaimer · Commercial interest
These statements have not been evaluated by the Food and Drug Administration. This guide is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before acting on any information presented here.
Commercial interest disclosure. Welyon produces an at-home H. pylori testing kit and a physician-supervised Foundation Protocol referenced in this guide. The presence of these products is disclosed throughout — including on this page, the guide cover, and in the front matter of the PDF — and does not change the content of the guide. The investigation steps described would apply equally if neither product existed.
Editorial independence. Evidence grading in this guide follows the same three-tier rubric used across the H. Pylori Investigation Series, applied identically regardless of whether the resulting investigation routes a reader toward — or away from — Welyon's products.